Product complaint # (b)(4). this report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided. the single complaint was reported with multiple events.There are no additional details regarding the additional events. citation: international urogynecology journal.2019; conference: 44th annual meeting of the american urogynecologic society and the international urogynecological association, augs-iuga 2019.Nashville, tn united states.30 (1 supplement): s282.Doi: https://hostedvl106.Quosavl.Com/qb/. attempts are being made to obtain the following information. to date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent. adverse events associated with prolift +m pelvic floor repair device reported via mw #2210968-2021-05021.
|
It was reported in a journal article with title: complications reported to the food and drug administration-a comparison of vaginal mesh products.The aim of this study is to compare vaginal prolapse mesh problems reported to the fda.To compare vaginal mesh device problems, a cross-sectional analysis of mdrs reported to the fda from 1/2004 to 3/2019 was analyzed using the reed tech navigator (lexisnexis, horsum pa), a software that codes medical device reports (mdrs).Chi2 and fisher exact tests with a dunn-sidak correction were used to compare complication proportions.Vaginal mesh products in the maude database were: gynecare prolift and prolift +m combined (ethicon) with n=6334 mdrs, while others from competitors.Reported complications included hematologic complaints (n=?), gynecologic complaints (n=?), pain (n=90.4%), erosion (n=91.2%), infection (n=18.2%), adverse event without identified device problem (n=11.6%), incontinence (n=?), prolapse (n=?), hemorrhage (n=?), urinary tract infection (n=?), unspecified injury (n=?), mesh erosion (n=19.5%), leak/splash (n=?), loose/intermittent connection (n=?), break (n=?), and detachment of device/component (n=?).In conclusion, reports to the fda on transvaginal mesh, a major data source for litigation, describe a wide range of adverse events with unverified biologic plausibility.The quality of data varies widely, and complication proportions may be affected by mesh groupings, market share, duration of time on the market, and trends in surgical placement.Further studies are needed to examine mesh complication profiles.
|